|Application ||WB, IHC-P, FC, E|
|Calculated MW||32335 Da|
|Antigen Region||56-84 aa|
|Other Names||CMRF35-like molecule 1, CLM-1, CD300 antigen-like family member F, Immune receptor expressed on myeloid cells 1, IREM-1, Immunoglobulin superfamily member 13, IgSF13, NK inhibitory receptor, CD300f, CD300LF, CD300F, CLM1, IGSF13, IREM1, NKIR|
|Target/Specificity||This CLM1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 56-84 amino acids from the N-terminal region of human CLM1.|
|Precautions||CLM1 Antibody (N-term) is for research use only and not for use in diagnostic or therapeutic procedures.|
|Synonyms||CD300F, CLM1, IGSF13, IREM1, NKIR|
|Function||Acts as an inhibitory receptor for myeloid cells and mast cells. Inhibits osteoclast formation.|
|Cellular Location||Cell membrane; Single-pass type I membrane protein|
|Tissue Location||Highly expressed in spleen, peripheral blood leukocyte and monocyte, and lung. Weakly expressed in thymus, heart, brain, placenta, liver, skeletal muscle, kidney, pancreas, prostate, testis, ovary, small intestine or colon. Expressed selectively in monocytes and monocyte-related cells|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
CLM1 is an inhibitory receptor of the Ig superfamily expressed on myeloid cells. It mediates negative regulatory signals by recruiting SHP1 (PTPN6; MIM 176883) or SHIP.
Danik, J.S., et al. Circ Cardiovasc Genet 2(2):134-141(2009)
Alvarez-Errico, D., et al. J. Immunol. 178(2):808-816(2007)
If you have any additional inquiries please email technical services at email@example.com.